Researchers at Weill Cornell Medicine, in collaboration with investigators at Dana-Farber Cancer Institute, have been awarded a three-year, $1 million grant from the U.S. Department of Defense (DoD) for prostate cancer clinical trials.

NewYork-Presbyterian Brooklyn Methodist Hospital’s Mobile Stroke Treatment Unit (MSTU) received a 2018 Champions and Visionaries of Healthcare Award at a recent event sponsored by the Brooklyn Daily Eagle and its long-standing parent company, EBrooklyn Media. The honorees were recognized for leading innovative health care practices that make a difference in patients’ lives in Brooklyn.

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that NewYork-Presbyterian Hospital will expand its telehealth capabilities with Philips remote patient monitoring.

Steven H. Silber, MS, DO, MHCM, has been named Regional Executive Medical Director of the NewYork-Presbyterian Medical Group Brooklyn. In his new role, Dr. Silber will be responsible for physician recruitment and retention, strategic growth, quality and access, and clinical integration with the large number of community-based physicians in Brooklyn.

NewYork-Presbyterian Hospital’s Nurse Residency Program has received Accreditation with Distinction from the American Nurses Credentialing Center, a recognition for excellence in transitioning nurses to new practice settings.

NewYork-Presbyterian, in collaboration with physicians from Columbia University Irving Medical Center, has launched a state-of-the-art sports medicine and performance training facility in Westchester County that gives patients and athletes access to some of the nation’s top sports medicine doctors, therapists, and elite sports performance coaches–all at a single location.

A set of gene variants that originated in Sub-Saharan West African populations may help explain why black women, compared to white women, have worse breast cancer outcomes, according to a new study from a team led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.

Dr. Martin B. Leon, director of the Center for Interventional Vascular Therapy at NewYork-Presbyterian/Columbia University Irving Medical Center, has been awarded the 2019 Lifetime Achievement Award by the American College of Cardiology (ACC) in honor of his contributions to the field of interventional cardiology — a branch of cardiovascular medicine that uses minimally invasive approaches to treating heart and valve diseases.